ORAL SCOPOLAMINE ANTIEMETIC EFFICACY VERSUS PLACEBO
This article was originally published in The Tan Sheet
Executive Summary
ORAL SCOPOLAMINE ANTIEMETIC EFFICACY VERSUS PLACEBO is supported by a recent clinical study by SeaTone and Upjohn submitted to FDA May 25, according to the study investigator. "Overall, the study is supportive to the efficacy of oral scopolamine with significant differences being found in subjects' final assessment of treatment effectiveness," the study report concludes.